255 related articles for article (PubMed ID: 12497747)
1. [Platelet antiaggregation and hemorrhagic risk in hemodialysis].
Sánchez Perales MC; Vázquez E; García Cortés MJ; Borrego FJ; Borrego J; Pérez del Barrio P; Liébana A; Gil JM; Viedma G; Pérez Bañasco V
Nefrologia; 2002; 22(5):456-62. PubMed ID: 12497747
[TBL] [Abstract][Full Text] [Related]
2. Influence of antiplatelet medications on bleeding events in hemodialysis patients.
Daimon S; Terai H
Ther Apher Dial; 2011 Oct; 15(5):454-9. PubMed ID: 21974698
[TBL] [Abstract][Full Text] [Related]
3. [Hemorrhagic complications from anticoagulant treatment: analysis of predictive risk factors].
Vázquez Ruiz de Castroviejo E; del Monte Trujillo Pérez M; Lozano Cabezas C; Avellaneda Molina C; Guzmán Herrera M; Martínez Galiano E; Pousibet Sanfeliú H; Tarabini Castellani A; Pagola Vilardebó C; Alcalá Muñoz A
Sangre (Barc); 1999 Jun; 44(3):216-21. PubMed ID: 10481584
[TBL] [Abstract][Full Text] [Related]
4. Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients.
Abraham NS; Hartman C; Richardson P; Castillo D; Street RL; Naik AD
Circulation; 2013 Oct; 128(17):1869-77. PubMed ID: 24025594
[TBL] [Abstract][Full Text] [Related]
5. Increased iron requirement in hemodialysis patients on antiplatelet agents or warfarin.
Flint S; Taylor E; Beavis J; Becker GJ; Pedagogos E
Nephron Clin Pract; 2009; 113(1):c38-45. PubMed ID: 19590234
[TBL] [Abstract][Full Text] [Related]
6. [Risk factors of upper gastrointestinal complications in outpatients on antiplatelet therapy: description and management].
Ducrocq G; Bigard MA; Marouene S; Delaage PH; Fabry C; Barthelemy P; Steg PG;
Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):245-51. PubMed ID: 22579299
[TBL] [Abstract][Full Text] [Related]
7. Lower GI bleeding is more common than upper among patients on dual antiplatelet therapy: long-term follow-up of a cohort of patients commonly using PPI co-therapy.
Casado Arroyo R; Polo-Tomas M; Roncalés MP; Scheiman J; Lanas A
Heart; 2012 May; 98(9):718-23. PubMed ID: 22523056
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors of gastrointestinal bleeding in patients on low-dose aspirin therapy after percutaneous coronary intervention in Japan.
Nadatani Y; Watanabe T; Tanigawa T; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Yoshiyama M; Arakawa T
Scand J Gastroenterol; 2013 Mar; 48(3):320-5. PubMed ID: 23298342
[TBL] [Abstract][Full Text] [Related]
9. [Hypertension in hemodialysis patients in Andalucia].
García Cortés MJ; Ceballos M;
Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
[TBL] [Abstract][Full Text] [Related]
10. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
11. Thienopyridine antiplatelet agents: focus on prasugrel.
Freeman MK
Consult Pharm; 2010 Apr; 25(4):241-57. PubMed ID: 20511177
[TBL] [Abstract][Full Text] [Related]
12. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
[TBL] [Abstract][Full Text] [Related]
13. Is it necessary to stop antiplatelet agents before a native renal biopsy?
Mackinnon B; Fraser E; Simpson K; Fox JG; Geddes C
Nephrol Dial Transplant; 2008 Nov; 23(11):3566-70. PubMed ID: 18503099
[TBL] [Abstract][Full Text] [Related]
14. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
Hsu PI
J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
[TBL] [Abstract][Full Text] [Related]
15. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
[TBL] [Abstract][Full Text] [Related]
16. PPI use in patients commenced on clopidogrel: a retrospective cross-sectional evaluation.
Luinstra M; Naunton M; Peterson GM; Bereznicki L
J Clin Pharm Ther; 2010 Apr; 35(2):213-7. PubMed ID: 20456741
[TBL] [Abstract][Full Text] [Related]
17. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
[TBL] [Abstract][Full Text] [Related]
18. Bleeding risks of combination vs. single antiplatelet therapy: a meta-analysis of 18 randomized trials comprising 129,314 patients.
Serebruany VL; Malinin AI; Ferguson JJ; Vahabi J; Atar D; Hennekens CH
Fundam Clin Pharmacol; 2008 Jun; 22(3):315-21. PubMed ID: 18485150
[TBL] [Abstract][Full Text] [Related]
19. Combination oral antiplatelet therapy may increase the risk of hemorrhagic complications in patients with acute ischemic stroke caused by large artery disease.
Itabashi R; Mori E; Furui E; Sato S; Yazawa Y; Fujiwara S
Thromb Res; 2011 Dec; 128(6):541-6. PubMed ID: 21741075
[TBL] [Abstract][Full Text] [Related]
20. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
Stojimirović B; Grujić-Adanja G
Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
